{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:03:38Z","timestamp":1787771018151,"version":"build-2784847793"},"reference-count":31,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"unspecified","delay-in-days":115,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2025,10,2]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Since the 1960s, beta blockers have been used to treat hypertrophic obstructive cardiomyopathy (HOCM), a genetic disorder causing abnormal heart muscle thickening. This systematic review evaluates their efficacy across clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Registered on PROSPERO (CRD42022344255), searches were performed in June 2022 and updated in September 2025 across MEDLINE, Embase, CINAHL and PubMed. Two reviewers independently screened studies. Meta-analysis was undertaken when \u22653 comparable datasets were available; otherwise, narrative synthesis was used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>21 studies including 775 adults met inclusion criteria. Beta blockers significantly reduced left ventricular outflow tract (LVOT) gradient (Standardised mean difference (SMD) \u20131.57; 95%\u2009CI \u20132.07 to \u20131.07) and heart rate (SMD \u20131.19; 95%\u2009CI \u20132.24 to \u20130.14). Sensitivity analyses confirmed the robustness of the LVOT effect, while heart rate effects remained heterogeneous. Improvements in New York Heart Association class, exercise tolerance and symptom burden were consistently reported, although data were subjective and small in scale. Mortality evidence was limited to two retrospective cohorts with divergent findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Beta blockers provide consistent haemodynamic and symptomatic benefits in HOCM, but most evidence derives from small, older studies with high risk of bias and limited survival data. Contemporary, adequately powered randomised controlled trials are required to define optimal agent selection, dosing and long-term outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42022344255<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2025-003460","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:25:47Z","timestamp":1761290747000},"page":"e003460","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Beta blockers and hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1528-3532","authenticated-orcid":false,"given":"Alexander James","family":"Smith","sequence":"first","affiliation":[{"name":"University Hospital Coventry, Coventry, Warwickshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1354-7779","authenticated-orcid":false,"given":"Amy Magaret Munro","family":"Cromie","sequence":"additional","affiliation":[{"name":"George Eliot Hospital NHS Trust, Nuneaton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5728-2582","authenticated-orcid":false,"given":"Libby","family":"Bowles","sequence":"additional","affiliation":[{"name":"Chesterfield Royal Hospital NHS Foundation Trust, Chesterfield, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3465-3626","authenticated-orcid":false,"given":"Thomas","family":"Anderson","sequence":"additional","affiliation":[{"name":"University Hospital Coventry, Coventry, Warwickshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2394-3231","authenticated-orcid":false,"given":"Jay","family":"Panchal","sequence":"additional","affiliation":[{"name":"Kettering General Hospital NHS Foundation Trust, Kettering, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5208-6446","authenticated-orcid":false,"given":"Ben","family":"Walters","sequence":"additional","affiliation":[{"name":"Doncaster and Bassetlaw Hospitals NHS Foundation Trust, Doncaster, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"2026010701112582000_12.2.e003460.1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15420\/ecr.2017:12:1","article-title":"Hypertrophic Cardiomyopathy in Athletes","volume":"12","author":"Malhotra","year":"2017","journal-title":"Eur Cardiol"},{"key":"2026010701112582000_12.2.e003460.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311059"},{"key":"2026010701112582000_12.2.e003460.3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs150"},{"key":"2026010701112582000_12.2.e003460.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00941-0"},{"key":"2026010701112582000_12.2.e003460.5","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(04)16358-7","article-title":"Hypertrophic cardiomyopathy","volume":"363","author":"Elliott","year":"2004","journal-title":"The Lancet"},{"key":"2026010701112582000_12.2.e003460.6","doi-asserted-by":"crossref","unstructured":"Maron BJ . Hypertrophic Cardiomyopathy. JAMA 2002;287. doi:10.1001\/jama.287.10.1308","DOI":"10.1001\/jama.287.10.1308"},{"key":"2026010701112582000_12.2.e003460.7","first-page":"53","article-title":"Hypertrophic cardiomyopathy: a review","volume":"8","author":"Houston","year":"2014","journal-title":"Clin Med Insights Cardiol"},{"key":"2026010701112582000_12.2.e003460.8","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jacc.2022.02.024","article-title":"Effects of Metoprolol on Exercise Hemodynamics in Patients With Obstructive Hypertrophic Cardiomyopathy","volume":"79","author":"Dybro","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026010701112582000_12.2.e003460.9","doi-asserted-by":"crossref","DOI":"10.1002\/clc.24207","article-title":"A systematic review of present and future pharmaco-structural therapies for hypertrophic cardiomyopathy","volume":"47","author":"Sawan","year":"2024","journal-title":"Clin Cardiol"},{"key":"2026010701112582000_12.2.e003460.10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijcard.2022.03.013","article-title":"Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study","volume":"354","author":"Monda","year":"2022","journal-title":"Int J Cardiol"},{"key":"2026010701112582000_12.2.e003460.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.04.051"},{"key":"2026010701112582000_12.2.e003460.12","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.44.5.488"},{"key":"2026010701112582000_12.2.e003460.13","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.38.5.846"},{"key":"2026010701112582000_12.2.e003460.14","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-019-01274-6","article-title":"Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy","volume":"19","author":"Imori","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"2026010701112582000_12.2.e003460.15","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.1.41"},{"key":"2026010701112582000_12.2.e003460.16","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.35.11.1116"},{"key":"2026010701112582000_12.2.e003460.17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.CIR.29.1.84","article-title":"EFFECTS OF BETA ADRENERGIC BLOCKADE ON THE CIRCULATION WITH PARTICULAR REFERENCE TO OBSERVATIONS IN PATIENTS WITH HYPERTROPHIC SUBAORTIC STENOSIS","volume":"29","author":"HARRISON","year":"1964","journal-title":"Circulation"},{"key":"2026010701112582000_12.2.e003460.18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/oxfordjournals.eurheartj.a061160","article-title":"Reappraisal of the effect of acute betablockade on left ventricular filling dynamics in hypertrophic obstructive cardiomyopathy","volume":"2","author":"Speiser","year":"1981","journal-title":"Eur Heart J"},{"key":"2026010701112582000_12.2.e003460.19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/4.suppl_F.47"},{"key":"2026010701112582000_12.2.e003460.20","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(73)90012-X"},{"key":"2026010701112582000_12.2.e003460.21","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90386-F"},{"key":"2026010701112582000_12.2.e003460.22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0167-5273(02)00312-1","article-title":"Beta-blocker therapy for dynamic left-ventricular outflow tract obstruction","volume":"86","author":"Al-Nasser","year":"2002","journal-title":"Int J Cardiol"},{"key":"2026010701112582000_12.2.e003460.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.07.065"},{"key":"2026010701112582000_12.2.e003460.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5492.895"},{"key":"2026010701112582000_12.2.e003460.25","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.32.6.804"},{"key":"2026010701112582000_12.2.e003460.26","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.35.5.847"},{"key":"2026010701112582000_12.2.e003460.27","doi-asserted-by":"publisher","DOI":"10.1159\/000175883"},{"key":"2026010701112582000_12.2.e003460.28","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.099416"},{"key":"2026010701112582000_12.2.e003460.29","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000963","article-title":"Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy","volume":"6","author":"Javidgonbadi","year":"2019","journal-title":"Open Heart"},{"key":"2026010701112582000_12.2.e003460.30","doi-asserted-by":"crossref","unstructured":"McGee K , Chu S , Choudhury L . Abstract 15251: Heart Failure With Preserved Ejection Fraction in Hypertrophic Cardiomyopathy With and Without Septal Myectomy. Circulation 2020;142. doi:10.1161\/circ.142.suppl_3.15251","DOI":"10.1161\/circ.142.suppl_3.15251"},{"key":"2026010701112582000_12.2.e003460.31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100622","article-title":"Medical Therapies to Improve Left Ventricular Outflow Obstruction and Diastolic Function in Hypertrophic Cardiomyopathy","volume":"2","author":"Zhu","year":"2023","journal-title":"JACC Adv"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2025-003460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:11:38Z","timestamp":1767777098000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2025-003460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,23]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/openhrt-2025-003460"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2025-003460","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}